News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
400,391 Results
Type
Article (11964)
Company Profile (117)
Press Release (388308)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (123991)
Career Advice (411)
Deals (21576)
Drug Delivery (44)
Drug Development (43581)
Employer Resources (36)
FDA (8692)
Job Trends (10550)
News (199108)
Policy (17114)
Tag
2027 Pharm Country Standard (2)
Academia (1689)
Accelerated approval (17)
Adcomms (6)
Allergies (110)
Alliances (21354)
ALS (103)
Alzheimer's disease (960)
Antibody-drug conjugate (ADC) (197)
Approvals (9021)
Artificial intelligence (274)
Autoimmune disease (95)
Automation (24)
Bankruptcy (147)
Best Places to Work (9401)
BIOSECURE Act (10)
Biosimilars (91)
Biotechnology (48)
Bladder cancer (107)
Brain cancer (36)
Breast cancer (469)
Cancer (3252)
Cardiovascular disease (267)
Career advice (346)
Career pathing (10)
CAR-T (188)
CDC (10)
Cell therapy (462)
Cervical cancer (29)
Clinical research (39251)
Collaboration (966)
Compensation (487)
Complete response letters (28)
COVID-19 (1266)
CRISPR (62)
C-suite (472)
Cystic fibrosis (87)
Data (4541)
Depression (81)
Diabetes (305)
Diagnostics (4561)
Digital health (25)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (117)
Drug pricing (56)
Drug shortages (8)
Duchenne muscular dystrophy (135)
Earnings (74031)
Editorial (19)
Employer branding (6)
Employer resources (34)
Events (79161)
Executive appointments (603)
FDA (10919)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (19)
Funding (855)
Gene editing (133)
Generative AI (17)
Gene therapy (327)
GLP-1 (464)
Government (2583)
Grass and pollen (5)
Guidances (373)
Healthcare (15132)
HIV (40)
Huntington's disease (28)
IgA nephropathy (57)
Immunology and inflammation (142)
Immuno-oncology (33)
Indications (71)
Infectious disease (1418)
Inflammatory bowel disease (138)
Inflation Reduction Act (7)
Influenza (80)
Intellectual property (128)
Interviews (65)
IPO (12683)
IRA (8)
Job creations (1426)
Job search strategy (303)
JPM (16)
Kidney cancer (11)
Labor market (43)
Layoffs (252)
Leadership (5)
Legal (3538)
Liver cancer (50)
Longevity (7)
Lung cancer (455)
Lymphoma (291)
Machine learning (13)
Management (11)
Manufacturing (430)
MASH (106)
Medical device (9895)
Medtech (9929)
Mergers & acquisitions (9708)
Metabolic disorders (690)
Multiple sclerosis (110)
NASH (5)
Neurodegenerative disease (175)
Neuropsychiatric disorders (47)
Neuroscience (1759)
Neurotech (1)
NextGen: Class of 2026 (5257)
Non-profit (4244)
Now hiring (22)
Obesity (266)
Opinion (80)
Ovarian cancer (111)
Pain (127)
Pancreatic cancer (150)
Parkinson's disease (194)
Partnered (14)
Patents (243)
Patient recruitment (277)
Peanut (43)
People (28049)
Pharmaceutical (15)
Pharmacy benefit managers (13)
Phase 1 (11639)
Phase 2 (17215)
Phase 3 (14014)
Pipeline (3974)
Policy (72)
Postmarket research (1182)
Preclinical (4048)
Press Release (61)
Prostate cancer (142)
Psychedelics (11)
Radiopharmaceuticals (165)
Rare diseases (511)
Real estate (2783)
Recruiting (16)
Regulatory (13643)
Reports (21)
Research institute (1544)
Resumes & cover letters (74)
Rett syndrome (22)
RNA editing (5)
RSV (38)
Schizophrenia (104)
Series A (143)
Series B (108)
Service/supplier (5)
Sickle cell disease (64)
Special edition (11)
Spinal muscular atrophy (95)
Sponsored (16)
Startups (1341)
State (1)
Stomach cancer (3)
Supply chain (48)
Tariffs (26)
The Weekly (8)
Vaccines (422)
Venture capital (31)
Weight loss (144)
Women's health (53)
Worklife (3)
Date
Today (11)
Last 7 days (325)
Last 30 days (1373)
Last 365 days (20772)
2026 (2354)
2025 (21928)
2024 (22587)
2023 (26923)
2022 (30893)
2021 (34999)
2020 (37341)
2019 (37138)
2018 (27037)
2017 (19874)
2016 (19678)
2015 (23190)
2014 (12766)
2013 (9617)
2012 (10164)
2011 (10407)
2010 (9422)
Location
Africa (298)
Alabama (54)
Alaska (2)
Arizona (174)
Arkansas (7)
Asia (24580)
Australia (3235)
California (7856)
Canada (1966)
China (903)
Colorado (339)
Connecticut (310)
Delaware (267)
Europe (47637)
Florida (1142)
Georgia (268)
Hawaii (1)
Idaho (38)
Illinois (604)
India (51)
Indiana (451)
Iowa (14)
Japan (289)
Kansas (77)
Kentucky (33)
Louisiana (21)
Maine (66)
Maryland (1078)
Massachusetts (5623)
Michigan (207)
Minnesota (454)
Mississippi (5)
Missouri (90)
Montana (29)
Nebraska (16)
Nevada (84)
New Hampshire (66)
New Jersey (2326)
New Mexico (18)
New York (2204)
North Carolina (1064)
North Dakota (4)
Northern California (3938)
Ohio (247)
Oklahoma (16)
Oregon (23)
Pennsylvania (1644)
Puerto Rico (9)
Rhode Island (33)
South America (536)
South Carolina (39)
South Dakota (1)
Southern California (3049)
Tennessee (112)
Texas (1192)
United States (28580)
Utah (260)
Vermont (1)
Virginia (196)
Washington D.C. (51)
Washington State (643)
West Virginia (1)
Wisconsin (67)
400,391 Results for "30".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cencora Closes $3.0 Billion Senior Notes Offering
February 15, 2026
·
4 min read
Press Releases
Sensient Announces Conference Call - January 30, 2026
February 2, 2026
·
1 min read
Press Releases
IO Biotech Provides Corporate Update - January 30, 2026
February 1, 2026
·
2 min read
Press Releases
Ryoncil® Net Revenues Increase for the Quarter to US$30M
January 29, 2026
·
9 min read
Press Releases
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
February 18, 2026
·
10 min read
Press Releases
Crescent Biopharma Announces Grants of Inducement Awards - January 30, 2026
February 2, 2026
·
1 min read
Press Releases
ALX Oncology Announces Pricing of Underwritten Offering - January 30, 2026
February 1, 2026
·
4 min read
Press Releases
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
January 14, 2026
·
3 min read
Press Releases
Bora Biologics Celebrates Opening of $30 Million San Diego Manufacturing Expansion
January 26, 2026
·
3 min read
Layoffs
InflaRx Stanches Spending With 30% Staff Reduction, Priority Pivot
Aside from the layoffs, InflaRx will deprioritize Gohibic, a COVID-19 antibody that was granted emergency use authorization in 2023. The therapy failed a late-stage trial in a rare skin disease last year.
January 9, 2026
·
1 min read
·
Tristan Manalac
1 of 40,040
Next
